missing translation for 'onlineSavingsMsg'
Learn More
Learn More
CD123 (IL-3Rα) Mouse, anti-Human, Unconjugated, Clone: 6H6, STEMCELL Technologies
Mouse Monoclonal Antibody
Marca: Stemcell Technologies 60110
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
- The 6H6 antibody reacts with human CD123 (IL-3 receptor subunit α), an ∼70 kDa type I transmembrane glycoprotein belonging to the type I cytokine receptor family (type 5 subfamily) and the immunoglobulin (Ig) superfamily
- CD123 constitutes the ligand-binding α chain of the heterodimeric IL-3 receptor
- CD123 binds IL-3 with low affinity per se, but when associated with CD131 (the signal-transducing β chain of the receptor), high-affinity binding of IL-3 is observed
- CD123 is expressed by hematopoietic progenitor cells, endothelial cells, basophils, eosinophils, mast cells, monocytes, macrophages, dendritic cells, megakaryocytes, a subset of B cells, and by neutrophils if cultured in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF)
- IL-3 binding to CD123 stimulates proliferation, differentiation, and viability of hematopoietic cells
- The 6H6 antibody does not inhibit binding of IL-3 to either CD123 or the IL-3 receptor
Especificaciones
| CD123 (IL-3Rα) | |
| Monoclonal | |
| Unconjugated | |
| 100 μg | |
| Rhesus Monkey, Sooty Mangabey, Human | |
| Dendritic Cells, Granulocytes and Subsets, Hematopoietic Stem and Progenitor Cells, Myeloid Cells |
| Immunohistochemistry, Western Blot, Flow Cytometry, Immunocytochemistry, Immunofluorescence | |
| 6H6 | |
| Mouse | |
| Primary | |
| IgG1 κ |
Corrección del contenido de un producto
El Programa Encompass de Fisher Scientific ofrece artículos que no forman parte de nuestra cartera de distribución. Estos productos no suelen tener imágenes ni descripciones detalladas. Sin embargo, nos comprometemos a mejorar su experiencia de compra. Utilice el siguiente formulario para hacernos llegar sus comentarios sobre el contenido de este producto.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido